| # | Drug | Count |
|---|---|---|
| 0 | EVEROLIMUS | 6 |
| 1 | ASFOTASE ALFA | 4 |
| 2 | EVEROLIMUS TABLETS | 4 |
| 3 | SECUKINUMAB | 3 |
| 4 | VEDOLIZUMAB | 3 |
| 5 | ASPIRIN | 2 |
| 6 | ASPIRIN 325 MG | 2 |
| 7 | ASPIRIN 81 MG | 2 |
| 8 | AZATHIOPRINE | 2 |
| 9 | CABERGOLINE | 2 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | DAPRODUSTAT | 1 | 0.0005 |
| 1 | LEBRIKIZUMAB-LBKZ | 1 | 0.0004 |
| 2 | CABERGOLINE | 2 | 0.0004 |
| 3 | ASFOTASE ALFA | 4 | 0.0004 |
| 4 | EVEROLIMUS TABLETS | 4 | 0.0002 |
| 5 | PERTUZUMAB, TRASTUZUMAB, AND HYALURONIDASE-ZZXF | 1 | 0.0002 |
| 6 | FENFLURAMINE | 1 | 0.0002 |
| 7 | NITROFURANTOIN MONOHYDRATE/MACROCRYSTALLINE | 1 | 0.0002 |
| 8 | IVABRADINE | 1 | 0.0001 |
| 9 | EVEROLIMUS | 6 | 0.0001 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Endoglycosidase [EPC] | 1 | 0.0005 |
| 1 | Hypoxia-inducible Factor Prolyl Hydroxylase Inhibitor [EPC] | 1 | 0.0004 |
| 2 | Ergot Derivative [EPC] | 2 | 0.0004 |
| 3 | Tissue-nonspecific Alkaline Phosphatase [EPC] | 4 | 0.0004 |
| 4 | Interleukin-13 Antagonist [EPC] | 1 | 0.0001 |
| 5 | Interleukin-17A Antagonist [EPC] | 3 | 0.0001 |
| 6 | Nitrofuran Antibacterial [EPC] | 1 | 0.0001 |
| 7 | Integrin Receptor Antagonist [EPC] | 3 | 0.0000 |
| 8 | Thiazide-like Diuretic [EPC] | 1 | 0.0000 |
| 9 | Purine Antimetabolite [EPC] | 2 | 0.0000 |